Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Vir Biotechnology (VIR) Is Up 24.8% After Strong SOLSTICE Combo Data In Hepatitis Delta Trial - Has The Bull Case Changed?
Vir Biotechnology (VIR) Is Up 19.4% After Strong Dual-Therapy Data in Hepatitis Delta Trial
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages
A Look At Vir Biotechnology (VIR) Valuation After New SOLSTICE Trial Data And Pipeline Updates
Vir Biotechnology (NASDAQ:VIR) Shares Up 9.9% - Should You Buy?
Reviewing Vir Biotechnology (NASDAQ:VIR) and Creative Medical Technology (NASDAQ:CELZ) - Stock Observer
Vir Biotechnology (NASDAQ:VIR) Trading 7.3% Higher - What's Next?
Vir Biotechnology (NASDAQ:VIR) Trading Up 7.3% - Should You Buy? - Daily Political
Vir Biotechnology (NASDAQ:VIR) Director Sells $130,460.00 in Stock - Daily Political
Company Website: https://vir.bio SAN FRANCISCO -- (Busines
Vicki Sato Sells 22,000 Shares of Vir Biotechnology (NASDAQ:VIR) Stock
Vir Biotechnology Inc. (VIR) - Insider Monkey
Brokerages Set Vir Biotechnology, Inc. (NASDAQ:VIR) Price Target at $17.30 - Markets Daily
Vir Biotechnology (NASDAQ:VIR) Stock Price Down 3.4% - Here's What Happened
VirBiotechnology News
Trending cryptos prediction: BTC recovers, ETH and XRP under pressure
Gold CFD trading tips for beginners: 5 steps to investing in gold in 2026
RIVN stock price prediction: RIVN crashes 31%, is Rivian a buy sell or hold?
TTD stock is trading down 7% today: What’s happening with Trade Desk Inc?
Nvidia invests $2 billion in CoreWeave: Will CRWV stock skyrocket in 2026?
